Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2020 Issue has been successfully launched on 1 November 2020

Abstract

DMF PREPARATIONS, REQUIREMENTS FOR MARKETING AUTHORIZATION AND PROCESS OF API IN EUROPEAN UNION

Y. Ratna Sindhu*, N. Sudarshini, Brahmaiah Bonthagarala, M. V. Nagabhushanam, G. Ramakrishna

ABSTRACT

The DMF preparation is most important to know exactly the pharmaceutical ingredient legislations (name, purity, intended use, adverse drug reactions). To submit a marketing authorization application (MAA) in all countries, it is important to know exactly the pharmaceutical legislations (regulations, directives and guidelines) and the regulatory requirements in each country in advance. For registration of drug products we need to know about the requirements for the registration of active pharmaceutical ingredients (API) which is the part of drug product and influences the quality of drug product. Due to the fact that the European Union (EU) and the United States (US) are the biggest and most potential markets for medicinal products in the world. Therefore within this dissertation a scientific requirement and recommendation for the registration of an active pharmaceutical ingredient is provided within these regulatory regions. The different pharmaceutical legislations and regulatory requirements for a new MAA of an API of EU are discussed and analyzed in detail. The analyses are made especially concerning the aspects required for marketing authorization and accepted dossier requirements for the registration of API in the EU.

Keywords: MAA, API, DMF, ASMF, FDA, EMEA.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More